Across TCGA pan-cancer cohorts, MIR548Q RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR548Q data layer.
The strongest signal is observed in mesothelioma (MESO), where higher MIR548Q RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548Q expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.
MESO, SKCM, and BLCA are the cancer types where MIR548Q RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.